
An exceptional runner’s fitness after eighty, a lifestyle trial’s aging-marker findings, and the cardio routine I use without universal dose claims.

Juan López García is 82. Retired mechanic. Toledo, Spain.
He didn't run until he was 66.
Researchers measured his VO2 max at 52.8 mL/kg/min when he was eighty-one. They described it as the highest they knew of in an octogenarian, around the seventieth percentile for healthy men aged twenty to thirty.
At eighty-one. That is remarkable. The same week, I read a randomized trial in frail older adults that reported favorable changes in epigenetic aging markers after a lifestyle program.
Neither promises Juan’s fitness or reversed aging for the rest of us. But both make me interested in what remains possible later in life.
In this issue:
- A lifestyle trial and what its age markers can tell us.
- Juan’s exceptional fitness, plus the cardio routine I use.
- AI-supported mammography, neural stem-cell research, and food-policy news.
A lifestyle trial changed aging markers
We've had observational data for years suggesting that exercise, nutrition, and social engagement slow biological aging. But observational data always has the same problem: maybe healthier people just exercise more. Correlation, not causation.
This month, a paper in Aging Cell (Olaso-Gonzalez, Gomez-Cabrera et al., Feb 2026) gave us the trial we've been waiting for. Researchers randomized frail older adults into two groups. One received a coordinated multidomain protocol - structured exercise, nutritional optimization, cognitive training, and social engagement. The other served as controls.
The intervention group showed favorable changes in selected epigenetic markers alongside functional outcomes. A lower clock value is not proof of whole-body rejuvenation, and the study cannot tell which part of the combined program caused the change.
📋 Key findings:
- Population: Frail older adults.
- Design: A combined exercise, nutrition, cognitive, and social program versus a control group.
- Outcome: Functional trajectories and selected DNA-methylation aging measures.
- Limit: The trial does not isolate social connection as the strongest component or prove longer life.
A separate Health and Retirement Study analysis linked social engagement with epigenetic-age measures. That observational result does not show that isolation causes faster biological aging or confirm the mechanism of the randomized trial.
An important caveat: a recent analysis in eBioMedicine (a Lancet journal) argues that epigenetic clocks still fall short of common standards for individual-level clinical utility. Population-level trends are robust, but telling you your precise biological age remains imprecise.
The science is moving fast - and it's moving in the right direction - but we're not yet at "order this test from your doctor" territory.
Exercise, adequate nutrition, and social connection are useful goals regardless of what a commercial age test reports.
I want to see whether those marker changes last and what they mean for health. They don’t yet show that human aging reversed.
Subscribe or share our newsletter for longevity updates
“Super López”: exceptional fitness after eighty
If that RCT is the population evidence, Juan López García is the individual case study.
Juan lives in Toledo, Spain. He spent his career as a freelance mechanic, working long hours fixing vehicles to make ends meet. Sport was a luxury he couldn't afford. He didn't run a single mile until he was 66, the year after he retired - when he walked 800 kilometers of the Camino de Santiago in 20 days and one of his daughters told him to try running.
He started slowly. A local group of distance runners in Toledo took him in. His friend Ricardo Ortega - a doctor and running coach - told him his pace put him among the top five in Spain for his age. Juan was surprised. He'd considered himself a complete beginner.
At 70, he entered his first cross-country championship and became champion of Spain. At 75, he went to the World Championships in Torun, Poland, and came back with four gold medals - 3,000m indoor, cross-country, 10K road (42:32, a Spanish record), and half marathon.
In 2025, he set the world record in the 50K ultramarathon: 4 hours, 47 minutes. Just last year, he won gold at the European Marathon with a time of 3:39 - averaging a 5:11 per kilometer pace. At 81.
His nickname in Spain is "Super López." Also: "the Toledo Kenyan."
The Frontiers in Physiology case study reported the 52.8 mL/kg/min measurement and examined what supported his performance.
To put that in perspective:
His value was around the seventieth percentile for healthy men aged twenty to thirty in the reference used by the authors. That is extraordinary at eighty-one. Comparisons with NFL players, Marines, or an absolute record holder use different tests and groups, so they are less helpful here.
He began running at sixty-six. His later fitness does not tell us how much came from training, inherited traits, or other factors.
The researchers also measured body composition. Lean mass includes more than muscle, so it should not be read as a direct comparison with young military personnel.
Why does he do it? Partly for the medals. But mainly because his wife Mari has a disability that requires his daily care, and the fitter he stays, the more he can help her.
"We all have problems at home… and when you start running you have the same problems, but they don't look so bad."
As a mechanic, Juan has his own theory about his longevity:
"I perform well now because I didn't wear out the engine when I was young."
The case describes a very high training volume. That is not realistic or suitable for most readers. It also does not show that a shorter high-intensity schedule reproduces Juan’s results.
A 2018 cohort study of 122,007 patients found a strong association between higher treadmill fitness and lower mortality. The elite-versus-low adjusted hazard ratio was 0.20. The study measured an association in referred patients, not the effect of assigning people more training.
The comparison with smoking in that analysis emphasizes the value of fitness; it does not mean poor fitness causes more harm than smoking in every person.
My Cardio Protocol (and How to Build Yours)
I combine moderate aerobic work with harder intervals. Both can improve fitness. Neither Juan’s case nor the mortality study establishes one required schedule for everyone.
A watch estimate can help track trends, but its error varies by person and device. My Apple Watch estimated forty; my lab test was five points higher. That difference is why a lab test can be useful when it would change your training or care; another person’s watch may behave differently.
A CPET measures gas exchange during exercise rather than estimating it from wrist data. If hard intervals are new to you, start below maximal effort and build gradually. Your health and symptoms determine whether you need clinical review first.
My moderate aerobic work
Moderate aerobic exercise can improve endurance and metabolic fitness. A 2025 review questioned claims that Zone 2 provides a uniquely strong mitochondrial stimulus for everyone.
I use a pace where I can still speak in full sentences. Heart-rate zones depend on how they are defined and on the person; “180 minus age” is not a reliable medical ceiling for everyone.
I like sessions of forty-five minutes or more, but there is no forty-five-minute switch for mitochondrial growth. Shorter sessions can still improve fitness.
I personally get 150-200 minutes of Zone 2 per week, split across Wednesday, Saturday, and Sunday in 45+ minute sessions. Modality doesn't matter much - cycling, brisk walking on an incline (I use a treadmill at 11% grade, 3 mph), rowing, swimming. Running works but it's harder to stay in Zone 2 as a beginner because your heart rate spikes easily.
One note: a 2025 review in Sports Medicine (Storoschuk et al.) challenged the "Zone 2 is magic" narrative, arguing higher intensities build mitochondria more efficiently per minute. They're correct, technically.
I find the combination practical: moderate sessions let me accumulate activity, and harder work challenges my aerobic capacity. The mix will depend on your goals and health.
The ceiling: high-intensity intervals, 1-2× per week
To move your VO2 Max, you need to signal to your body that its current oxygen delivery system isn't sufficient, forcing adaptation.
My weekly split:
Tuesday - short HIIT: 30-second all-out sprints with rest breaks, repeated twice. This is pure neuromuscular power and anaerobic capacity. Short, sharp, done.
Friday: I use Norwegian four-by-four intervals, one studied way to improve aerobic fitness.
- Warm up for ten minutes.
- Do four minutes of hard effort that I can sustain for the full interval.
- Recover actively for three minutes.
- Repeat the hard interval four times in total.
- Cool down for five to ten minutes.
With warm-up and cool-down, the session takes roughly forty to fifty minutes. I adjust the effort, pace, and mode to my fitness and recovery.
I can use an incline walk or a bike when running does not fit. Each mode has its own demands on joints and muscles, so I choose based on comfort, symptoms, and recovery.
Moderate work and intervals can improve different parts of fitness. Juan’s case doesn’t tell us the best mix for longevity, or show exactly how each interval changes the heart.
A workable weekly plan
My example combines several moderate sessions with one interval session. A reader can start with less and build a schedule they can sustain.
The mortality study’s lack of an observed upper fitness limit is not proof that ever more exercise is better or risk-free. Training load and recovery still matter.
Moderate-to-hard steady exercise can also help. Zone 3 is not a wasted or harmful “no-man’s-land.” Choose intensities that fit your goals and recovery.
⚡ Quick Hits
🤖 AI-supported mammography in a randomized trial
The Swedish MASAI trial randomized 105,934 women to AI-supported screening or standard double reading. The AI workflow triaged exams to one or two radiologists; interval-cancer rates met noninferiority, and sensitivity was higher. Breast arterial calcification screening was not this trial’s reported endpoint.
Related research: MASAI trial.
🧠 A protein that reactivates aging brain cells
NUS researchers identified DMTF1 as a master regulator of neural stem cell activity (Science Advances). Mechanism: telomere shortening → DMTF1 loss → brain cell decline. Pre-clinical, but specific and plausible.
🍟 Kennedy signals the biggest food policy shift in decades
RFK Jr. told CBS' 60 Minutes the FDA "will act on" reclassifying sweeteners - including corn syrup - as no longer GRAS. No regulatory action yet. Watching for rulemaking, not rhetoric.
🤝 Social connection as epigenetic medicine
JAGS data linked social engagement with selected age measures. Calling a friend may support connection and well-being; it is not a validated epigenetic treatment.
🫀 Until Next Week
Juan started at sixty-six. His story is a good reason to take late-life fitness seriously, even if his results are exceptional. The lifestyle trial adds evidence about function and aging markers; it still cannot tell someone how long they will live.
None of this requires a prescription.
Choose one repeatable change this week, whether it is a walk, a strength session, or time with someone you care about.
To your healthspan,
Hillary Lin, MD
Co-Founder & CEO, Curator
Want to turn your wellness brand into a full-service health destination?Learn about Curator's platform or Get Started Here
Events listed when this issue was published
I'll be at the Integrative Healthcare Symposium in NYC - Feb 19-21. Let me know if you're there and we can sync up!
👱🏻♀️👩🏻🦰👩🏻👧🏽👧🏾 Livelong Women's Health Summit: April 17-18, 2026, SF, CA. Delighted to join 50 other thought leaders in speaking on women's longevity! (Code HILLARY50 for $50 off)
Offers listed when this issue was published
This issue included an affiliate offer from NeuroAgeTx. Check current services and prices before buying.
This issue included a Timeline offer for urolithin A. Human studies assess selected muscle, mitochondrial, and immune measures; they do not establish a human lifespan benefit. Check current terms.
GlycanAge reports an age estimate from IgG glycosylation. It doesn’t diagnose the cause of inflammation or establish how to treat it.
I have liked ZBiotics products. That preference is not proof that they extend life or offset alcohol’s health risks. Check current offer terms.
The Longevity Letter
A weekly read on tests, treatment, and claims.
New issues look at what the evidence supports, what is premature, and what to skip.